Venous Involvement in Takayasu Disease: A Case Report
Published: 2022-12-24
Page: 247-253
Issue: 2022 - Volume 4 [Issue 1]
Meriem El Mousaid *
Département de Cardiologie, CHU Ibn Rochd, N°1 Quartier des Hopitaux, 24200, Casablanca, Morocco.
Essadqi Fadwa
Département de Cardiologie, CHU Ibn Rochd, N°1 Quartier des Hopitaux, 24200, Casablanca, Morocco.
Asmaa Elamraoui
Département de Cardiologie, CHU Ibn Rochd, N°1 Quartier des Hopitaux, 24200, Casablanca, Morocco.
Keltoum Boumlik
Département de Radiologie, CHU Ibn Rochd, N°1 Quartier des Hopitaux, 24200, Casablanca, Morocco.
Rachida Habbal
Département de Cardiologie, CHU Ibn Rochd, N°1 Quartier des Hopitaux, 24200, Casablanca, Morocco.
*Author to whom correspondence should be addressed.
Abstract
Takayasu's disease (TD) is an inflammatory arteritis of the large vessels that affects with predilection the aorta and its main branches, the thickening of the vascular wall is the most characteristic early sign of the disease leading progressively to stenoses, thromboses and occasionally the development of aneurysms. It is a vasculitis that generally spares the veins, few cases of deep vein thrombosis (DVT) have been reported during this pathology. It is in this order that we report the case of a 48-year-old patient followed for a month in the internal medicine department for Takayasu's disease, a diagnosis established because of her young age, female gender, abolition of pulses in the lower limbs and the radiological aspect. The patient underwent treatment with high-dose corticosteroid therapy (prednisone 1 mg/kg per day). For DVT, she was put on DOAC. The evolution under treatment was marked by the regression of the inflammatory signs and the negativation of the infectious assessment. Addressing this issue is important as the risk of restenosis or occlusion is still high with vascular interventions.
Keywords: Takayasu disease, deep vein thrombosis, vasculitis, aorta